C12Y 401/01008
Oxalyl-coa decarboxylase
Official title: Oxalyl-CoA decarboxylase (4.1.1.8)
C12Y401/01008 (Oxalyl-coa decarboxylase) appears on 9 US grants and 18 published applications in this corpus.
Search patents in C12Y- Granted patents
- 9
- Published applications
- 18
- Assignees
- 11
- Inventors
- 43
- Latest grant
- 23 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 2 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 1 | 0 |
| 2014 | 1 | 1 |
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 1 | 1 |
| 2019 | 1 | 1 |
| 2020 | 1 | 1 |
| 2021 | 0 | 0 |
| 2022 | 1 | 3 |
| 2023 | 1 | 3 |
| 2024 | 0 | 1 |
| 2025 | 2 | 1 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Methods and compositions for treating hyperoxaluria23 Sep 2025US 12,421,518 B2Tenza, Inc.
- Co-production pathway for 3-HPA and acetyl-CoA derivatives from malonate semialdehyde5 Aug 2025US 12,378,580 B2Braskem S/A
- High efficiency oxalate-degrading enzymes for degradation of insoluble and soluble oxalate14 Mar 2023US 11,603,524 B2Oxidien Pharmaceuticals, LLC
- Co-production pathway for 3-HPA and acetyl-CoA derivatives from malonate semialdehyde5 Jul 2022US 11,377,671 B2Braskem S/A
- Compositions and methods for treating or preventing oxalate-related disease19 May 2020US 10,653,726 B2Oxthera Intellectual Property AB
- Orthogonal metabolic framework for one-carbon utilization19 Mar 2026US 2026/0078416 A1Mojia Biotech Pte. Ltd.
- Acyloin Condensation Reactions, Enzymes, and Products Thereof4 Dec 2025US 2025/0369024 A1Mojia Biotech Pte. Ltd.
- Bacteria engineered to treat disorders in which oxalate is detrimental20 Jun 2024US 2024/0197843 A1Synlogic Operating Company, Inc.
- Microbial consortia1 Jun 2023US 2023/0165913 A1Federation Bio, Inc.
- Bacteria engineered to treat disorders in which oxalate is detrimental23 Mar 2023US 2023/0092431 A1Synlogic Operating Company, Inc.
Most cited
By later US patents
- Compositions and methods for treating or preventing oxalate-related disease19US 8,486,389 B2Oxthera, Inc. · 2013
- Compositions and methods for oxalate reduction5US 8,900,575 B2Oxthera Intellectual Property AB · 2014
- Compositions and methods for treating or preventing oxalate-related disease4US 10,149,866 B2Oxthera Intellectual Property AB · 2018
- Compositions and methods for treating or preventing oxalate-related disease1US 10,653,726 B2Oxthera Intellectual Property AB · 2020
- Co-production pathway for 3-HPA and acetyl-CoA derivatives from malonate semialdehyde1US 11,377,671 B2Braskem S/A · 2022